Clinical Trial Update: JACTAX LD Drug Eluting Stent Trial [NA]

View source ↗

Summary

A completed clinical trial for the JACTAX LD Drug Eluting Stent sponsored by Boston Scientific in coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• JACTAX LD Drug Eluting Stent

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Coronary Artery Disease | NA | Status: COMPLETED